Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Apply
OR502
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step